Top

European Archives of Psychiatry and Clinical Neuroscience

Published in:

01-11-2009

Future classification of psychotic disorders

Authors: Wolfgang Gaebel, Jürgen Zielasek

Published in: European Archives of Psychiatry and Clinical Neuroscience | Special Issue 2/2009

Abstract

Reclassifying psychotic disorders in the upcoming revisions of the mental disorders section of ICD-10 and DSM-IV will first necessitate the development of a unified and operationalized definition of the term “psychosis”. Ideally, such a definition would be harmonized between both groups of diagnostic classification systems and become part of a glossary of terms. Conceptually and based on epidemiological and some genetic work, incorporating dimensional criteria and criteria for prodromal high-risk symptoms may become feasible. Considering the currently available evidence from genetic, neuroimaging and neurophysiological studies, none seems yet sufficiently validated to warrant major changes. However, further research in these areas promises to yield important new insights which may become relevant for the classification of psychotic disorders in the near future. Given the rapid progress in these fields, regular updates of the classification criteria at shorter intervals than in the past may become necessary.

Allardyce J, Gaebel W, Zielasek J, Van Os J (2007) Deconstructing psychosis conference 2006: the validity of schizophrenia and related approaches to the classification of psychosis. Schizophr Bull 33:863–867CrossRefPubMed

American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders, 3rd edn. American Psychiatric Association, Washington, pp 367–368

American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn, Text Revision. American Psychiatric Association, Washington, p 827CrossRef

Barch DM, Carter CS, Arnsten A, Buchanan RW, Cohen JD, Geyer M, Green MF, Krystal JH, Nuechterlein K, Robbins T, Silverstein S, Smith EE, Strauss M, Wykes T, Heinssen R (2009) Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meeting. Schizophr Bull 35:109–114CrossRefPubMed

Bassett DS, Bullmore ET (2009) Human brain networks in health and disease. Curr Opin Neurol 22:340–347CrossRefPubMed

Bullmore E, Barnes A, Bassett DS, Fornito A, Kitzbichler M, Meunier D, Suckling J (2009) Generic aspects of complexity in brain imaging data and other biological systems. Neuroimage 47:1125–1134CrossRefPubMed

Ferrarini L, Veer IM, Baerends E, van Tol MJ, Renken RJ, van der Wee NJ, Veltman DJ, Aleman A, Zitman FG, Penninx BW, van Buchem MA, Reiber JH, Rombouts SA, Milles J (2009) Hierarchical functional modularity in the resting-state human brain. Hum Brain Mapp 30:2220–2231CrossRefPubMed

Galderisi S, Mucci A, Volpe U, Boutros N (2009) Evidence-based medicine and electrophysiology in schizophrenia. Clin EEG Neurosci 40:62–77PubMed

Go RC, Perry RT, Wiener H, Bassett SS, Blacker D, Devlin B, Sweet RA (2005) Neuregulin-1 polymorphism in late onset Alzheimer’s disease families with psychoses. Am J Med Genet Neuropsychiatr 1398:28–32CrossRef

10.

Gur RE, Keshavan MS, Lawrie SM (2007) Deconstructing psychosis with human brain imaging. Schizophr Bull 33:921–931CrossRefPubMed

11.

Hall J, Whalley HC, Job DE, Baig BJ, McIntosh AM, Evans KL, Thomson PA, Porteous DJ, Cunningham-Owens DG, Johnstone EC, Lawrie SM (2006) A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nat Neurosci 12:1477–1478CrossRef

12.

He Y, Wang J, Wang L, Chen ZJ, Yan C, Yang H, Tang H, Zhu C, Gong Q, Zang Y, Evans AC (2009) Uncovering intrinsic modular organization of spontaneous brain activity in humans. PLoS One 4:e5226CrossRefPubMed

13.

Hyman SE (2007) Can neuroscience be integrated into the DSM-V? Nat Rev Neurosci 8:725–732CrossRefPubMed

14.

Kapur S (2003) Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatr 60:13–23CrossRef

15.

Kendell R, Jablensky A (2003) Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry 160:4–12CrossRefPubMed

16.

Keri S, Kiss I, Kelemen O (2009) Effects of a neuregulin 1 variant on conversion to schizophrenia and schizophreniform disorder in people at high risk for psychosis. Mol Psychiatr 14:118–119CrossRef

17.

Koutsouleris N, Meisenzahl EM, Davatzikos C, Bottlender R, Frodl T, Scheuerecker J, Schmitt G, Zetzsche T, Decker P, Reiser M, Möller HJ, Gaser C (2009) Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition. Arch Gen Psychiatry 66:700–712CrossRefPubMed

18.

Kraepelin E (1920) Die Erscheinungsformen des Irreseins. Z ges Neurol Psychiatr 62:1–29CrossRef

19.

Martin LF, Hall MH, Ross RG, Zerbe G, Freedman R, Olincy A (2007) Physiology of schizophrenia, bipolar disorder, and schizoaffective disorder. Am J Psychiatr 164:1900–1906CrossRefPubMed

20.

Meisenzahl EM, Seifert D, Bottlender R, Teipel S, Zetzsche T, Jäger M, Koutsouleris N, Schmitt G, Scheuerecker J, Burgermeister B, Hampel H, Rupprecht T, Born C, Reiser M, Möller HJ, Frodl T (2009) Differences in hippocampal volume between major depression and schizophrenia: a comparative neuroimaging study. Eur Arch Psychiatry Clin Neurosci (in press). doi:10.1007/s00406-009-0023-3

21.

Meunier D, Achard S, Morcom A, Bullmore E (2009) Age-related changes in modular organization of human brain functional networks. Neuroimage 44:715–723CrossRefPubMed

22.

Nelson B, Fornito A, Harrison BJ, Yücel M, Sass LA, Yung AR, Thompson A, Wood SJ, Pantelis C, McGorry PD (2009) A disturbed sense of self in the psychosis prodrome: linking phenomenology and neurobiology. Neurosci Biobehav Rev 33:807–817CrossRefPubMed

23.

Owen MJ, Craddock N, Jablensky A (2007) The genetic deconstruction of psychosis. Schizophr Bull 33:905–911CrossRefPubMed

24.

Regier DA (2007) Time for a fresh start? Rethinking psychosis in DSM-V. Schizophr Bull 33:843–845CrossRefPubMed

25.

Regier DA, Narrow WE, Kuhl EA, Kupfer DJ (2009) The conceptual development of DSM-V. Am J Psychiatry 166:645–650CrossRefPubMed

26.

Sackett DL, Haynes RB (2002) Evidence base of clinical diagnosis: the architecture of diagnostic research. BMJ 324:539–541CrossRefPubMed

27.

Shahrokh NC, Hales RE (2003) American psychiatric glossary, 8th edn. American Psychiatric Publishing, Washington

28.

Sullivan PF, Lin D, Tzeng JY, van den Oord E, Perkins D, Stroup TS, Wagner M, Lee S, Wright FA, Zou F, Liu W, Downing AM, Lieberman J, Close SL (2008) Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol Psychiatry 13:570–584CrossRefPubMed

29.

The International Schizophrenia Consortium (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature (in press). doi:10.1038/nature08185

30.

Valencia M, Pastor MA, Fernández-Seara MA, Artieda J, Martinerie J, Chavez M (2009) Complex modular structure of large-scale brain networks. Chaos 19:023119CrossRefPubMed

31.

World Health Organization (1992) The ICD-10 classification of mental and behavioural disorders. World Health Organization, Geneva, pp 3–4

32.

Zielasek J, Gaebel W (2008) Modern modularity and the road towards a modular psychiatry. Eur Arch Psychiatry Clin Neurosci 258(Suppl 5):60–65CrossRefPubMed

Title: Future classification of psychotic disorders
Authors: Wolfgang Gaebel
Jürgen Zielasek
Publication date: 01-11-2009
Publisher: D. Steinkopff-Verlag
Published in: European Archives of Psychiatry and Clinical Neuroscience / Issue Special Issue 2/2009
Print ISSN: 0940-1334
Electronic ISSN: 1433-8491
DOI: https://doi.org/10.1007/s00406-009-0049-6

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Future classification of psychotic disorders

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 2/2009

Would the use of dimensions instead of categories remove problems related to subthreshold disorders?

Global mental health: the role of psychiatry

Repetitive transcranial magnetic stimulation for the treatment of negative symptoms in residual schizophrenia: rationale and design of a sham-controlled, randomized multicenter study

Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment

Brain imaging: on the way toward a therapeutic discipline

Future perspectives in psychotherapy